3651 results for «283»
3651 results
Rapid-fire - Complex procedure in TAVI - Part 1
17 Feb 2024 – From PCR Tokyo Valves 2024
In the first part of this rapid-fire session, we focus on complex cases that might arise during TAVI, such as how to navigate a permanent pacemaker implantation, TAVI in a post-liver transplant patient with severe aortic regurgitation, or complex TAVI by transcarotid access.
Rapid-fire - Complications of Mitral TEER - Part 1
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases. Learn about what might cause a loud rumbling sound after intervention, and explore a rare complication of the MitraClip procedure.
TAVI for patients with concomitant coronary artery disease - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...
PCR Tokyo Valves 2024 Welcome Ceremony
17 Feb 2024 – From PCR Tokyo Valves 2024
After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...
How to optimise lifetime management of TAVI patients with long life expectancy?
17 Feb 2024 – From PCR Tokyo Valves 2024
In this special session sponsored by Abbott, gain insight into how valve design and features may influence clinical outcomes and future interventions. Learn about hemodynamic efficiency of TAVI valves, and understand the factors influencing durability and clinical performance over time.
Challenges in TEER for secondary mitral regurgitation
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...
TAVI in challenging anatomies
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about how to manage complex anatomy and complications during TAVI. Learn about successful cases of PTMC and TAVI performed simultaneously, gain insight into TAVI considerations and techniques for a very severely calcified aortic valve, and explore a scientific and safe...
Rapid-fire - Mitral TEER for special situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
